Can We Beat Cancer? AI, mRNA, and the Future of Living Longer | Longevity, Episode 2

AI is revolutionizing cancer detection by enabling earlier, more accurate diagnoses through machine learning models that analyze medical imaging, genetic data, and patient histories to identify high-risk cases before symptoms appear. Cancer rates among young adults (under 50) are rising globally, with experts linking the trend to environmental factors, lifestyle changes, and improved diagnostic tools uncovering previously undetected early-stage cases. mRNA technology, proven in COVID-19 vaccines, is being adapted to create personalized cancer treatments and preventive vaccines, targeting tumor-specific mutations with clinical trials already underway for melanoma and pancreatic cancer. Health disparities remain a critical barrier, as cutting-edge therapies and AI-driven diagnostics are disproportionately accessible to wealthy nations and patients, exacerbating global inequities in cancer survival rates. Experts emphasize prevention as the future of oncology, combining AI-driven risk assessment, mRNA-based immunotherapies, and policy changes to reduce late-stage diagnoses and shift focus toward proactive, precision medicine.